China’s Nationwide Medical Merchandise Administration (NMPA) has accepted a supplemental biologics license utility (sBLA) looking for the approval of ivonescimab (AK112; SMT112) monotherapy...
Praful Okay. Ravi, MB, BChir, MRCP, medical oncologist, Lank Middle for Genitourinary Oncology, Dana-Farber Most cancers Institute, teacher, medication, Harvard Medical College, discusses...